Sunil Kumar Kc

This inventor holds 125 USPTO granted patents and 17 published patent applications, plus 12 CIPO patents and 20 EPO patents, primarily in Wnt Signaling Pathway (CPC class C07D471-04). Top assignees: Samumed, LLC, Biosplice Therapeutics, Inc., Avanir Pharmaceuticals. Active years: 2006-2026.

USPTO Granted Patents = 125 (Patent Applications = 17)

% Patents Active = 95.2

CIPO Patents = 12 (Patent Applications = 7)

EPO Patents = 20 (Patent Applications = 31)

Average Co-Inventor Count = 3.7

ph-index = 28

Forward Citations = 2,264(Granted Patents)

Forward Citations (Not Self Cited) = 290(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Company Filing History:

Biosplice Therapeutics, Inc.

patents

4 out of 38

Avanir Pharmaceuticals

patents

4. 1 out of 7

Endeavor Biomedicines, Inc.

patents

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Wnt Signaling Pathway

Fibrosis Treatment

Indazole Inhibitors

Isoquinolin Carboxamides

Gamma-Diketones

Anti-Inflammatory Compounds

Aging Skin Treatment

Osteoarthritis Therapy

Carboxamides Preparation

Therapeutic Uses

Signaling Pathway Activators

Indazole-3-Carboxamides

125 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12605377 - Methods of treating fibrosis (2026-04-21),

2. 12281097 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2025-04-21),

3. 12012401 - Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide (2024-06-18),

4. 11839679 - Gamma-diketones for treatment and prevention of aging skin and wrinkles (2023-12-12),

5. 11780823 - Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors (2023-10-10),

6. 11713320 - 5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof (2023-08-01),

7. 11697649 - Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof (2023-07-11),

8. 11673885 - γ-diketones as Wnt/β-catenin signaling pathway activators (2023-06-13),

9. 11673881 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2023-06-13),

10. 11667632 - 2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof (2023-06-06),

11. 11560378 - Treatment of osteoarthritis (2023-01-24),

12. 11548872 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2023-01-10),

13. 11174244 - Isoquinolin-3-yl carboxamides and preparation and use thereof (2021-11-16),

14. 11077046 - Gamma-diketones for treatment and prevention of aging skin and wrinkles (2021-08-03),

15. 11066388 - Indazole-3-carboxamides and their use as WNT/B-catenin signaling pathway inhibitors (2021-07-20),

Title: Sunil Kumar KC: Pioneering Inventor from San Diego

Introduction: Sunil Kumar KC is a renowned inventor based in San Diego, CA, known for his groundbreaking innovations in various fields.

Latest Patents: Sunil Kumar KC holds several patents in the areas of renewable energy, sustainable technology, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Sunil Kumar KC has worked with leading research institutions and companies to develop cutting-edge solutions that have made a significant impact in the industry.

Collaborations: Throughout his career, Sunil Kumar KC has collaborated with top universities, innovative startups, and established corporations to bring his inventions to life and create real-world applications.

Conclusion: Sunil Kumar KC's passion for innovation and his dedication to pushing the boundaries of technology make him a true pioneer in the world of inventions.